1st Quarter - Report

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
$1,480,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1730/S. 670- Speeding Therapy Access Today Act; H.R. 483/S. 350 - Newborn Screening Saves Lives Act; H.R. 6000 Cures 2.0 Act; H.R. 6584 Diverse and Equitable Participation in Clinical Trials Act; S. 2706/H.R. 5030 Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act; H.R. 6963 - Accelerated Approval Integrity Act; H.R. 6996 - Accelerating Access for Patients Act - General issues related to rare disease and orphan drugs; Reauthorization of the FDA User Fee Act; FDA modernization policy issues; Reauthorization of newborn screening programs; Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients; General issues related to health equity in rare disease and clinical trials; General issues related to diagnostics for patients with rare diseases Cancer screening, diagnosis & treatment Prescription drug electronic labeling H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act; H.R. 19 - Lower Costs, More Cures Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 - Build Back Better Act H.R. 3085/S. 1548 -ENACT Act of 2021 H.R. 5585 - Advanced Research Project Agency-Health Act H.R. 2883, Stop Stalling Access to Affordable Medications Issues related to COVID-19 vaccines and therapies; Items related to the Administrations Cancer Moonshot S. 3799, the PREVENT Pandemics Act S. 3509 Creating Efficiency in Foreign Facility Inspections Act Prescription Drug User Fee Act (PDUFA)

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
THADDEUS FLOOD —
AARON W HUNTER —
KATIE JONES —
CAROLINE QUAT —

Contacted: White House Office; Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 483 (117th), S. 350 (117th), H.R. 6584 (117th), H.R. 1730 (117th), H.R. 3 (117th), H.R. 19 (117th), H.R. 6996 (117th), H.R. 6000 (117th), S. 3509 (117th), H.R. 5260 (117th), H.R. 3085 (117th), S. 2706 (117th), H.R. 5585 (117th), H.R. 6963 (117th), S. 3799 (117th), H.R. 2883 (117th), H.R. 5376 (117th), S. 670 (117th), H.R. 5030 (117th), S. 1548 (117th)

Medicare/Medicaid MMM

H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act; H.R. 19 - Lower Costs, More Cures Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 - Build Back Better Act - General issues related to patient access to rare disease therapies, Part B and Part D drugs; Issues related to home infusion for Part B patients; Center for Medicare and Medicaid Innovation (CMMI) policy issues; Value-based payment arrangements; Efforts to improve coding, coverage, and access for rare disease therapies; Issues related to low volume Diagnosis Related Groups (DRGs) and rare therapies; General issues related to diagnostic reimbursement S. 1873/H.R. 1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
THADDEUS FLOOD —
AARON W HUNTER —
KATIE JONES —
CAROLINE QUAT —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (117th), S. 1873 (117th), H.R. 19 (117th), H.R. 5260 (117th), H.R. 1946 (117th), H.R. 5376 (117th)

Pharmacy PHA

Issues related to the 340B drug discount program. Discussions related to an appropriations hold on funding for a 2014 FDA rule that would move package inserts (PI) from paper to digital form-e-labeling.

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
AARON W HUNTER —
CAROLINE QUAT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Issues relating to Intellectual Property protections for Covid-19 treatments and vaccines. H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act. H.R. 2884, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act. H.R. 2891 Preserve Access to Affordable Generics and Biosimilars Act H.R. 4521 America COMPETES Act of 2022

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
AARON W HUNTER —
KATIE JONES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2873 (117th), H.R. 2891 (117th), H.R. 2884 (117th), H.R. 4521 (117th)

Taxation/Internal Revenue Code TAX

H.R. 2623 - Camerons Law; H.R. 5376 - Build Back Better Act; Issues related to the Orphan Drug Tax Credit; Issues related to the deduction of research and development expenditures Issues related to corporate and international tax reform

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
KATIE JONES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th), H.R. 2623 (117th)

Budget/Appropriations BUD

Issues related to an appropriations hold on funding for a 2014 FDA rule that would provide electronic flexibilities related to package inserts (PI); Appropriations, FY 2022 and FY 2023; H.R. 2471, Consolidated Appropriations Act, 2022 H.R. 2471; Public Service Retirement Fairness Act of 2021

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
THADDEUS FLOOD —
AARON W HUNTER —
KATIE JONES —
CAROLINE QUAT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2471 (117th)

Copyright/Patent/Trademark CPT

Issues related to intellectual property, data exclusivity, patent eligibility & patent law reform S. 1435, the Affordable Prescriptions for Patients Act

LobbyistCovered position, as disclosed
SUSIE AHN —
ELIZABETH BROOKS —
HELEN DWIGHT —
THADDEUS FLOOD —
AARON W HUNTER —
KATIE JONES —
CAROLINE QUAT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1435 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.